FULC

FULCRUM THERAPEUTICS INC

FULC·359616109·US·Common Stock·Healthcare - Biotechnology-13D/G

FULC (FULCRUM THERAPEUTICS INC) is held by 99 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($46.4M), BlackRock, Inc. ($41.3M), VANGUARD CAPITAL MANAGEMENT LLC ($20.7M). Net institutional sentiment: Bullish.

99
Holders
Avg rating(21 Elite)
$304.9M
Total Value
67% (109)
Fund Consensus
69 buying - 34 selling
FULCSmart Money Verdict
View all
Held by 99 funds
21 elite
Who's Trading
ActivistECEcoR1 Capital, LLC9.0%Jun 25, 2026
ActivistECEcoR1 Capital, LLC9.0%Jun 25, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC8.2%Jun 10, 2026
ActivistNANantahala Capital Management, LLC4.6%May 15, 2026
ActivistTCTCG Crossover GP II, LLC7.9%May 15, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderGJGould Robert JSell $178KJan 2, 2026
InsiderOGOltmans Curtis GaleSell $45KDec 15, 2025
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $18.4MDec 8, 2025
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $38.6MDec 8, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.1M$46.4M0.5%-48.39%
0
Increased
5.4M(+26.4%)$41.3M0.0%-42.00%
36
New
2.7M$20.7M0.0%-55.53%
39
Increased
2.2M(+76.4%)$17M0.0%-63.65%
43
Decreased
2.1M(-13.5%)$15.9M0.0%-69.14%
0
Increased
1.8M(+83.4%)$13.7M0.0%-53.44%
43
Decreased
1.6M(-15.2%)$12.5M0.0%-56.21%
0
Increased
1.5M(+54.2%)$11.9M0.0%-44.53%
39
Increased
1.5M(+34.4%)$11.4M0.0%-57.26%
36
New
1.3M$10.2M0.0%-55.53%
38
Increased
1.3M(+7.1%)$9.9M0.0%-60.26%
30
New
1.2M$9.2M0.0%0.00%
38
Increased
1.1M(+7.5%)$8.7M0.0%-41.94%
30
Increased
974,739(+148.3%)$7.5M0.0%-62.23%
44
Increased
736,684(+26.5%)$5.7M0.0%-54.42%
33
New
599,379$4.6M0.0%-55.53%
37
Increased
571,909(+76.6%)$4.4M0.0%-49.65%
41
Increased
543,165(+3403.8%)$4.2M0.0%-56.08%
43
Decreased
472,985(-14.3%)$3.6M0.0%-34.52%
0
Increased
453,529(+27.6%)$3.5M0.0%-66.56%
33

Showing 1-20 of 109

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used